[Skip to Content]
[Skip to Content Landing]
Views 71
Citations 0
Comment & Response
August 24, 2017

The Hereditary Paraganglioma-Pheochromocytoma Syndrome: No Time to Waste—Reply

Author Affiliations
  • 1Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston
  • 2Department of Sarcoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston
JAMA Oncol. Published online August 24, 2017. doi:10.1001/jamaoncol.2017.2503

In Reply We thank Dr Hall and his colleagues for their thoughtful comments about our case report of a gastrointestinal stromal tumor (GIST) in a pregnant young woman.1 They highlighted the high incidence of succinate dehydrogenase (SDH) deficiency among patients with wild-type (WT) GISTs and the importance of performing germline testing of SDH genes in such patients to diagnose hereditary paraganglioma/pheochromocytoma syndrome (HPPS). The diagnostic criteria and clinical manifestations of HPPS have been detailed thoroughly in their letter. Therefore, we will take this opportunity to highlight some of the key features in the diagnosis and management of WT and SDH-deficient GIST.

First Page Preview View Large
First page PDF preview
First page PDF preview